Mariam Eatedali on Medicare

Washington Healthcare Update - August 2019 #2

Congress - House - In Recess - Cummings and Sanders Seek Information About Possible Obstruction of a Congressional Investigation on Generic Drug Prices...more

8/20/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Generic Drugs , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - August 2019 #1

Congress - House - House Passes Short-Term Funding Extension for Medicaid Pilot Program - On July 30, the House passed a bill to keep a $1 billion Medicaid pilot providing mental health and addiction services running...more

8/6/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , Medicaid , Medicare , Opioid , Pharmaceutical Industry , Physicians , Prescription Drugs , Trump Administration

Washington Healthcare Update June 2019 #3

This week in Washington: Senate to hold hearing on the enforcement of antitrust laws, while the House plans to cover a number of health care bills that reauthorize a variety of health programs for Americans. The House may...more

6/25/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Opioid , Prescription Drugs

Washington Healthcare Update May 2019 #2

This week in Washington: House to hold hearings on PFAS contamination and exposure, the maternal mortality crisis and single-payer issues....more

5/14/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Congressional Budget Office , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Inpatient Prospective Payment System (IPPS) , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Pharmacy Benefit Manager (PBM) , Popular , Prescription Drugs , Trump Administration

Washington Healthcare Update May 2019

This week in Washington: Hearings continue on the price of prescription drugs, Senate Committee on Finance to hold a hearing on Medicare physician payment reform, while the Senate HELP Committee will hold its second hearing...more

5/7/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Inpatient Prospective Payment System (IPPS) , Medicare , Medicare for All , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Popular , Prescription Drugs , Trump Administration

Washington Healthcare Update April 2019 #3

Congress - Hearings/Markups - Senate Finance Committee: "Drug Pricing in America: A Prescription for Change, Part III" - Tuesday, April 9, 2019: The Senate Finance Committee continued its drug pricing series by...more

4/16/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare for All , OMB , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Trump Administration

Washington Healthcare Update March 2019 #2

Coming Week’s Highlights: CMS seeks recommendations that allow Americans to purchase health insurance across state lines, House to hold hearings on the 2020 HHS budget and lowering the cost of prescription drugs....more

3/12/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Nursing Homes , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update March 2019 #1

Upcoming Hearings - Tuesday, March 5, 2019 - Senate Committee on Health, Education, Labor and Pensions (HELP): “Vaccines Save Lives: What is Driving Preventable Disease Outbreaks?” - The Senate Committee on Health,...more

3/5/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Comment Period , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance Portability and Accountability Act (HIPAA) , Medicare , OMB , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs

Washington Healthcare Update February 2019 #3

Upcoming Hearings - Tuesday, Feb. 26, 2019 - Senate Finance Committee: “TBA Hearing on Drug Pricing” - The second hearing in a series on drug pricing in the Senate Finance Committee will include the testimonies of...more

2/19/2019 / Centers for Medicare & Medicaid Services (CMS) , Comment Period , Department of Health and Human Services (HHS) , Drug Pricing , Health Care Providers , Medicare , Medicare Part D , OMB , Opioid , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Washington Healthcare Update February 2019 #2

Coming Week’s Highlights: This week’s focus by many will be whether the government shuts down once more. Legislation must be passed and signed by the President by February 15, in order to keep the departments not yet funded...more

2/12/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Washington Healthcare Update February 2019 #1

Coming Week’s Highlights: State of the Union scheduled for Feb. 5; House committees continue discussion on pre-existing conditions....more

2/5/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Congressional Budget Office , Department of Health and Human Services (HHS) , Drug Pricing , GAO , Medicare , Medicare Advantage , Medicare Part D , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Section 340B

Washington Healthcare Update: January 2019 #3

This Week: The government shutdown continues; Congress finishes organizing and finalizing committee members and begins to focus on the issues. Concern has been raised that the Centers for Medicare and Medicaid Innovation...more

1/23/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , GAO , Medicaid , Medicare , Medicare Part D , Pharmaceutical Industry

Mariam Eatedali

McGuireWoods LLP

Popular Topics by This Author

Latest Posts › Medicare